In this advanced-level webinar, Dr. Jennifer Stagg will outline the next step in a holistic protocol for managing small intestinal bacterial overgrowth (SIBO), focusing on why recurrence is so common and how to prevent it. With over 20 years of clinical experience in integrative medicine, Dr. Stagg will explain why Phase 1 antimicrobial treatment alone is not enough—where almost half of patients see symptom relapse within 9 months, and many remain at high risk. Phase 2 targets the deeper dysfunctions that drive overgrowth: impaired digestive secretions and disrupted gut motility. This session will help clinicians optimize long-term outcomes through evidence-informed tools that address root causes.
Key Learning Points:
- Understand what’s going wrong beneath recurrent SIBO: insufficient stomach acid, enzymes, and bile, as well as disrupted intestinal motility.
- Learn how to correct digestive secretions through functional support of acid, bile, and enzyme production.
- Explore motility-focused strategies to support the migrating motor complex (MMC) and vagal tone.
- Recognize the impact of advanced age and medications—especially the rise of GLP-1 receptor agonists—on gut function and relapse risk.
- Gain insight into why Phase 1 is incomplete without Phase 2 care and how to implement a relapse-prevention protocol.
- Develop a practical, holistic approach to sustain microbial balance and GI function long after initial antimicrobial regimen ends
